SC 13G/A: Jaguar Health, Inc.
Ticker: JAGX · Form: SC 13G/A · Filed: 2024-07-22T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Jaguar Health, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001462830-24-000003 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001462830-24-000003 Filing Date 2024-07-22 Accepted 2024-07-22 16:10:52 Documents 1 Group Members FIFE TRADING, INC.ILIAD MANAGEMENT, LLCJOHN M. FIFE Document Format Files Seq Description Document Type Size 1 13G/A jagx.txt SC 13G/A 9591 Complete submission text file 0001462830-24-000003.txt 11380 Mailing Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601 Business Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-565-1569 Iliad Research & Trading, L.P. (Filed by) CIK : 0001462830 (see all company filings) EIN. : 113688679 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300 Jaguar Health, Inc. (Subject) CIK : 0001585608 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-88872 | Film No.: 241131621 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)